Coronary artery disease, microalbuminuria and lipid profile in patients with non-insulin dependent diabetes mellitus

Arquivos Brasileiros de Cardiologia

Volumn 73, Issue 1, 1999, Pages 17-22

  Bahia, Luciana ^a   Gomes, Maríla B ^a   Di Marco da Cruz, Pedro ^a   De Fátima Gonçalves, Maria ^a  

^a NONE

Author keywords

Coronary artery disease; Diabetes mellitus; Lipid disorders; Microalbuminuria

Indexed keywords

LIPID;

ALBUMINURIA; ARTICLE; BLOOD; BLOOD PRESSURE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ALBUMINURIA; BLOOD PRESSURE; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0039029075     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0066-782X1999000700002     Document Type: Article

References (45)

1. Eastman RC, Kenn H. The impact of cardiovascular disease on people with diabetes: the potencial for prevention. Lancet 1997; 350(suppl I): 29-32.
2. Cunha EP, Marques EP, Gomes MB. Perfil de pacientes diabéticos intemados em Hospital Universitário no Rio de Janeiro. Arq Bras Endocrinol Metab 1992; 39: 111-15.
3. Jarret RJ, Viberti GC, Argyropoulos A, et al. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984; 1: 17-19.
4. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Eng J Med 1984; 310: 356-60.
5. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993; 7: 996-1003.
6. Niskanen L, Uusitupa M, Sarlund H, et al. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 diabetic patients. Diabetologia 1990; 33: 237-43.
7. Haffner SM, Morales PA, Gruber MK, Hazuda HP, Stern MP. Cardiovascular risk factors in non insulin-dependent diabetic subjects with microalbuminuria. Arterioscler Thromb 1993; 13: 205-10.
8. Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E, and the WHO Multinational Study Group. Proteinuria and Mortality in Diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetic Med 1995; 12: 149-55.
9. Deckert T, Feldt-Rasmussen B, Borsch-Johnsenk K, et al. Albuminuria reflects widespread vascular damage. The steno hypothesis. Diabetologia 1989; 32: 219-26.
10. Stehouwer CDA, Nauta JJ, Zeldenrust GC, et al. Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-23.
11. Yudkin JS. Microalbuminuria: a genetic link between diabetes and cardiovascular disease? Ann Med, 1992; 24: 517-22.
12. Friedwald WT, Levy RJ, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
13. Detection and Management of Lipid Disorders in Diabetes. Consensus of American Diabetes Association. Diabetes Care, 1996.
14. World Health Organization: Measuring Obesity: Classification and Description of Anthropometric Data, Copenhagen, WHO, 1989.
15. Chase HP, Jackson WE, Hoops S, et al. Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 1989; 261: 1150-60.
16. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Int Med 1993; 153: 154-83.
17. Consenso Nacional de Ergometria. Arq Bras Cardiol 1995; 65: 190-211.
18. Gatling W, Knight C, Mullee MA, Hill RD. Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabetic Med 1988; 5: 343-7.
19. Olivarius N, Andreasen AH, Keiding N, Mogensen CE. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly-diagnosed patients:cross-sectional data from the population-based study "Diabetes care in general practice", Denmark. Diabetologia 1993; 36: 1007-16.
20. Schimtd A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin dependet diabetes: a 10 year follow-up study of 503 patients. Diabetic Med 1987; 5: 126-34.
21. Patrick AW, Williams Z. The natural history and associations of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabetic Med 1990; 7: 902-8.
22. Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects. The Insulin Resistance Atherosclerosis Study. Diabetes 1998; 47: 793-800.
23. Uusitupa M, Siitonen O, Penttil AL, et al. Proteinuria in newly diagnosed type 2 diabetic patients. Diabetes Care 1987; 10: 191-4.
24. Gall MA, Rossing P, Skott P, et al. Prevalence of micro and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-61.
25. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic ratinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 1996; 19: 1243-8.
26. Lee KU, Park JY, Kim SW, et al. Prevalence and associated features of albuminuria in koreans with NIDDM. Diabetes Care 1995; 18: 793-5.
27. Torffvit O, Agardh E, Agardh CD. Albuminuria and associated medical risk factors: a cross-section study in 451 type II (noninsulin-dependent) diabetic patients. Part 2. J Diabetic Compl 1991; 5: 29-34.
28. Burto BT, Foster WR. Health implications of obesity:an NIH consensus development conference. J Am Diet Assoc 1985; 85: 1117-21.
29. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med 1993; 153: 154-83.
30. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-62.
31. Gomes MB, Lucchetti MR, Gazzola H, Dimetz T, Lobão VI, Sturm JA. Perfil lipídico, microalbuminúria e pressão arterial sistêmica em pacientes com diabetes insulino-dependente. Arq Bras cardiol 1997; 68: 85-9.
32. Nelson RG, Sievers ML, Knowler WC, et at. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 1990; 81: 987-95.
33. Kannel WB. Lipids, diabetes and coronary heart disease: insights from the Framingham Study. Am Heart J 1985; 110: 1100-7.
34. Uusitupa M, Siitonen O, Aro A. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-age newly diagnosed type 2 diabetic patients. Diabetologia 1985; 28: 22-7.
35. Gall MA, KB-Johnsen, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995; 44: 1303-9.
36. Groop L, Forlblon C, Lehtovirta M, et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 diabetes mellitus. Diabetologia 1993; 36: 642-7.
37. Consenso Brasileiro sobre Dislipidemia: detecção-avaliação-tratamento. Arq Bras Cardiol 1996; 67: 109-28.
38. Taskinen MR. Diabetic dyslipidemia in NIDDM. International Diabetes Monitor 1996; 8: 1-7.
39. Stern MP, Mitchell BD, Haffner SM, Hazuda HP. Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? Diabetes Care 1992; 15: 638-44.
40. Luz PL, Carvalho MEA, Cardoso RH, Gallocci SDB, Pileggi F. Incidência de dislipidemia e sua relação com doença arterial coronária em populações brasileiras. Arq Bras Cardiol 1990; 54: 257-64.
41. Abraira C, Colwell JA, Nuttall SQ, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type 2 diabetes (VACSDM): Results of the feasibility trial. Diabetes Care 1995; 18: 1113-23.
42. Passarelli M, Catonozi S, Nakandakare ER, Morton RE, Shimabukuro AFM. Quintão ECR. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and "in vivo" glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins. Diabetologia 1997; 40: 1085-93.
43. Koistinen MJ, Huikuri HV, Korhonen UR, et al. Asymptomatic coronary heart disease in diabetes: realtion to comum risk factors, lipoproteins, apoproteins and apoE polymoephism. Acta Diabetol 1994; 31: 210-14.
44. Mattock MB, Keen H, Viberti GC, et al. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia l988; 31: 82-7.
45. Mackness S, Mackness MI, Arrol S, et al. Serum paraoxanase (PONI) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 1998; 139: 341-9.